Antonio Troia

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Increased expression of fetal hemoglobin (HbF) may ameliorate the clinical course of hemoglobinopathies. Hydroxyurea (HU) is the only inducer approved for the treatment of these diseases able to stimulate HbF production but patients' response is highly variable indicating the utility of the identification of pharmacogenomic biomarkers in order to predict(More)
  • 1